Life With GLP-1s
Clinical and cultural conversations around obesity have long revolved around BMI (and its credibility), harmful stereotypes, issues of equity and the multi-million dollar weight loss industry.
Read Resource
Omada Health Resource Center
Clinical and cultural conversations around obesity have long revolved around BMI (and its credibility), harmful stereotypes, issues of equity and the multi-million dollar weight loss industry.
Read Resource
A side-effect of taking GLP-1s is a loss of muscle mass. Julie Mulcahy, PT, DPT, CAPP OB explores how to combat this with resistance exercises.
Read Article
Omada Health, the virtual-first healthcare provider, published its 28th peer-reviewed study demonstrating the long-term outcomes of utilizing a behavior change program for members with type 2 diabetes
Read Article
Become an Omada Insider, subscribe to our monthly newsletter.
Sign me upLisa McCormick, FNP-BC, RD, CDCES explores the science behind dieting and why it doesn't work. Find out more about sustainable weight loss!
Read Article
Findings show that meaningfully engaged Omada members on GLP-1s achieved an average of 1.7 times greater weight loss, and inform a new collaboration with Evernorth's EncircleRx program.
Read Article
Obesity is now widely recognized as a lifelong chronic disease–but what’s behind that evolution? Join us to find out!
Read Article
Leading Innovation at NEBGH 13th Annual Health and Wellness Benefits Conference
Read Article
Join Us at HLTH 2024 in Las Vegas!
Read Article
Pioneering Transformation at AHIP 2024 Consumer Experience and Digital Health Forum
Read Article
Omada Health: Shining as a Gold Level Sponsor at AHIP 2024!
Read Article
Charting New Frontiers at the Lockton People Solutions Conference 2024
Read Article
A proud Gold Sponsor of the 2024 Thrive experience! Join our leaders, Tom Maraday and Kevin Masci on Thursday, April 11!
Read Article
Building on more than a decade of insights and 28 peer-reviewed publications, Omada announces plans to develop more learnings focused on the long-term outcomes of GLP-1s on weight health
Read Article
Omada delivers GLP-1 FAQs focusing on weight loss quantity vs. quality with timely data and insights for employers, health plans and benefit consultants.
Read Article
Omada Health Customer Case Study: Learn how Essentia Health surpassed enrollment and engagement goals in its diabetes programs, and how they market virtual care solutions to their population.
Read Article
Omada Health Enhances GLP-1 Care Track to Support Customers Managing Medications and Integrates MSK Support.
Read Article
Obesity is one of the clearest case studies of health disparities that exist in the U.S., having the biggest impact on Black and Hispanic adults, low-income populations, and people covered by Medicaid
Read Article
GLP-1 agonist medications have had impressive initial outcomes. However, the long-term effects on a patient’s health beyond the trial timelines and on the costs to the healthcare system are uncertain.
Read Article
This Proof Points edition is based on the article Can Type 2 Diabetes be Reversed? Here’s What the Research Says.
Read Article
The purpose of this study is to examine the long-term impact of a digital diabetes self-management education and support (DSMES) program on A1C among adults with type 2 diabetes (T2DM).
Read Article
Loading More...